30 reports

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

The MicroPEARLS spray freezing technology allows for the timely release of these two key nutrients throughout an animal' s gastrointestinal (GI) tract.

  • Mineral Supplement
  • World
  • Market Size
  • Ajinomoto Co., Inc.
  • Cargill Inc.
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

It is used to enhance rumen and gastrointestinal tract function.

  • Cattle
  • Mineral Supplement
  • World
  • Market Size
  • Nutreco N.V.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

The alleviation of gastrointestinal morbidity and other diseases in livestock, such as swine dysentery and acidosis in ruminants, is another advantage of feed ingredients enzymes.

  • Mineral Supplement
  • Colombia
  • South America
  • Market Size
  • Alltech Inc.

MARKET SEGMENTATION ##.

  • Mineral Supplement
  • Argentina
  • Croda International Plc
  • Danone SA
  • General Mills, Inc.

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

The company produces and markets high-quality products and biologics in the areas of gastrointestinal disease, neurology, psychiatry, immunology, pain control, infectious disease, and oncology.

  • Cancer Hormonal Therapy
  • Mineral Supplement
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

THE MOST COMMON GRADE ##-## ADVERSE EVENTS INCLUDED NEUTROPENIA (##%), HYPOKALEMIA (##%), HYPOPHOSPHATEMIA (##%), RASH (##%), TUMOR FLARE (##%) AND GASTROINTESTINAL COMPLAINTS (##%).

  • Cancer Hormonal Therapy
  • Targeted Therapy
  • United States
  • Demand
  • Celgene Corporation

OPROZOMIB IS ASSOCIATED WITH GASTROINTESTINAL TOXICITIES, WITH THE MOST COMMON GRADE ## AES BEING DIARRHEA, NAUSEA, AND VOMITING.

  • Cancer Hormonal Therapy
  • Market Size
  • Celgene Corporation
  • Janssen Biotech, Inc.
  • Novartis AG

Oprozomib is associated with gastrointestinal toxicities, with the most common Grade ## AEs being diarrhea, nausea, and vomiting.

  • Cancer Hormonal Therapy
  • Janssen Biotech, Inc.
  • Novartis AG
  • PharmaMar SA
  • Takeda Pharmaceutical Company Limited

Oprozomib is associated with gastrointestinal toxicities, with the most common Grade ## AEs being diarrhea, nausea, and vomiting.

  • Cancer Hormonal Therapy
  • Janssen Biotech, Inc.
  • Novartis AG
  • PharmaMar SA
  • Takeda Pharmaceutical Company Limited

Oprozomib is associated with gastrointestinal toxicities, with the most common Grade ## AEs being diarrhea, nausea, and vomiting.

  • Cancer Hormonal Therapy
  • National Comprehensive Cancer Network, Inc.
  • Novartis AG
  • PharmaMar SA
  • Takeda Pharmaceutical Company Limited

Oprozomib is associated with gastrointestinal toxicities, with the most common Grade ## AEs being diarrhea, nausea, and vomiting.

  • Cancer Hormonal Therapy
  • United States
  • National Comprehensive Cancer Network, Inc.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited

It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.

  • Endocrine Disease
  • Mineral Supplement
  • United States
  • World
  • Product Initiative

Common toxicities were hematological and gastrointestinal.

  • Cancer Hormonal Therapy
  • Mineral Supplement
  • Oncology
  • United States
  • Acetylon Pharmaceuticals, Inc.
  • 1.1 MARKET DEFINITION

Such drugs with sensorial effects are mainly developed in the cough, cold & allergy and gastrointestinal categories.

  • Mineral Supplement
  • OTC
  • Spain
  • Forecast
  • Sanofi S.A.

DLTs were Gr## asthenia (n = ##) and Gr## mood altered (n = ##) at ## mg; and Gr## neutropenia (n = ##) and Gr## and Gr## hyperglycemia (n = ## each) at ## mg.

  • Cancer Hormonal Therapy
  • Pathology
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Mineral Supplement
  • World
  • Celgene Corporation

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Monoclonal Antibody
  • World
  • Product Initiative

A single infusion of CAEL-## or one weekly infusion for four weeks have demonstrated early and sustained organ response in cardiac, renal, gastrointestinal, skin and soft tissue.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Mineral Supplement
  • World
  • Product Initiative

Gastrointestinal adverse events were generally manageable with antiemetics.

  • Cancer
  • Cancer Hormonal Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • Clinical Trial Profile Snapshots

(Inactive) ## AXIS Clinicals Limited ## Bluefish Pharmaceuticals AB ## F.

  • Breast Cancer
  • Cancer Hormonal Therapy
  • Hormone
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Mineral Supplement
  • Oncology
  • World
  • Product Initiative

In general, it is assumed that prebiotics mainly increase the activity of lactobacilli and bifidobacteria in the gastrointestinal tract.

  • Mineral Supplement
  • Europe
  • European Union
  • World
  • Market Size